.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers have introduced TotalX, a scalable method for single-cell total RNA sequencing. Traditionally, single-cell atlases focused only on polyadenylated (poly(A)) transcripts. Consequently, these maps missed crucial noncoding RNAs that regulate gene expression. This new framework integrates with standard droplet-based platforms. Therefore, it offers a unified pipeline for diverse RNA biotypes, including miRNA and tRNA.
The study applied TotalX to the developing human brain. The team identified biotype-specific programs across all neuronal lineages. Specifically, they tracked microRNA dynamics in Cajal-Retzius neurons. Furthermore, researchers found a significant anticorrelation between MIR137 and its targets. Since MIR137 is linked to schizophrenia and intellectual disability, this discovery suggests tight regulatory control during cortical development.
Beyond neurology, the framework analyzed human peripheral blood mononuclear cells (PBMCs). It identified transcriptional modules combining coding and noncoding RNAs. Additionally, the researchers studied dengue-infected hepatocytes. TotalX successfully captured non-adenylated viral transcripts. This capability allows doctors to distinguish infection states more accurately. Indeed, this expanded coverage helps in understanding cellular identity and gene regulation at the atlas scale.
Standard methods primarily capture polyadenylated messenger RNA. TotalX expands this by capturing noncoding RNAs, including microRNA and tRNA, using a unified droplet-based pipeline.
MIR137 is a microRNA associated with schizophrenia and intellectual disability. This sequencing technology reveals its specific enrichment in Cajal-Retzius neurons. It shows how noncoding RNA guides early brain development.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Isakova A et al. Scalable single-cell total RNA sequencing unifies coding and noncoding transcriptomics. Nat Biotechnol. 2026 Mar 31. doi: 10.1038/s41587-026-03068-6. PMID: 41917462.
Duan J, et al. MIR137 and its target genes in schizophrenia. North Am J Med Sci. 2014.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
TotalX enables scalable single-cell total RNA sequencing, capturing coding and noncoding RNAs to reveal regulatory insights in brain development and infecti...
5 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
